Malignant neoplasms of respiratory and intrathoracic organs Clinical Trials

10 clinical trials for Malignant neoplasms of respiratory and intrathoracic organs across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer — RECRUITING · PHASE1
• Biomarkers and pathomechanisms in chronic lung diseases — RECRUITING
• Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serum — RECRUITING
• Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT — ACTIVE_NOT_RECRUITING · PHASE1
• Acquisition of optical and olfactory sensory impressions directly during radiation therapy with protons or photons — OTHER
• Heidelberg Milestone-Communication Approach (Heidelberger Meilenstein-Kommunikationskonzept, HeiMeKOM) - A Mixed-Method Study — OTHER
• Heidelberg Milestone-Communication Approach (Heidelberger Meilenstein-Kommunikationskonzept, HeiMeKOM) - A randomized controlled trial — OTHER
• Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy — COMPLETED
• Lenvatinib and Capecitabine in Patients With Advanced Malignancies — WITHDRAWN · PHASE1
• Patient empowerment and risk–assessment to improve outcome in the elderly after gastrointestinal, thoracic or urogenital cancer surgery - Pilot study — OTHER

Refine this search